CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 2,098.20
-14.80 (-0.70%)
At close: Jul 27, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 128.33 billion as of July 27, 2026.
Market Cap
128.33B
Enterprise Value
129.69B
Revenue
14.03B
Ranking
n/a
PE Ratio
69.32
Stock Price
2,098.20
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 128.33B, an increase of 45.87%. That is a compound annual growth rate of 85.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 128.33B | 51.51% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 256.35B |
| Granules India | 208.78B |
| AstraZeneca Pharma India | 204.20B |
| Caplin Point Laboratories | 199.39B |
| Jubilant Pharmova | 154.95B |
| Viyash Scientific | 113.41B |
| Procter & Gamble Health | 112.57B |